Table 3.
Clinico-pathologic characteristics of 101 EOC patients and their association with LipB mRNA expression
| Parameters | Fold change | 95%CI | p-value |
|---|---|---|---|
|
Histological type |
|
|
|
| Serous vs endometrioid |
0.84 |
0.25-2.22 |
0.773 |
| Serous vs clear cell |
3.43 |
0.002-0.79 |
0.027 |
| Serous vs mucinous |
1756 |
0.66-3.83 |
0.345 |
| Serous vs mixed |
1.05 |
0.51-2.34 |
0.533 |
| Serous vs undifferentiated |
12.99 |
1.80-7.88 |
0.007 |
| Endometrioid vs clear cell |
4.04 |
0.66-2.83 |
0.265 |
| Endometrioid vs mucinous |
2069 |
0.46-3.73 |
0.487 |
| Endometrioid vs mixed |
1.24 |
0.27-2.32 |
0.765 |
| Endometrioid vs undifferentiated |
15.31 |
0.96-1.73 |
0.094 |
| Clear cell vs mucinous |
511 |
0.36-3.52 |
0.446 |
| Clear cell vs undifferentiated |
3.78 |
0.46-2.94 |
0.269 |
| Mixed vs clear cell |
3.25 |
0.71-3.72 |
0.151 |
| Mixed vs mucinous |
1660 |
0.36-3.54 |
0.412 |
| Mixed vs undifferentiated |
12.28 |
0.007-0.89 |
0.036 |
| Undifferentiated vs mucinous |
135 |
0.22-3.77 |
0.990 |
|
Histological grade |
|
|
|
| G2 + G3 vs G1 |
0.04 |
0.003-0.59 |
0.02 |
|
FIGO stage |
|
|
|
| III + IV vs I + II |
0.80 |
0.29-2.14 |
0.66 |
|
Age at diagnosis (y) |
|
|
|
| >60 vs ≤60 |
1.09 |
0.512-2.335 |
0.58 |
|
Residual tumor (RT), cm |
|
|
|
| RT > 0 vs RT = 0 |
0.99 |
0.41-2.38 |
0.99 |
|
Presence of ascites |
|
|
|
| yes vs no |
1.69 |
0.76-3.73 |
0.19 |
|
Lymph node involvement |
|
|
|
| positive vs negative | 1.03 | 0.42-2.52 | 0.94 |